Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells
暂无分享,去创建一个
H. Weiner | M. Mazzola | Anu Paul | R. Gandhi | V. Beynon | Felipe von Glehn | Roopali Gandhi | Keren Regev | Anu Paul | Radhika Raheja | Pia Kivisakk | K. Regev | Maria Antonietta Mazzola | Vanessa Beynon | Isabelle Pierre | Howard L Weiner | R. Raheja | F. von Glehn | P. Kivisakk | A. Paul | Isabelle V. Pierre
[1] A. Compston,et al. Multiple sclerosis. , 2002, Lancet.
[2] G. Mancardi,et al. Dendritic Cells in Multiple Sclerosis Lesions: Maturation Stage, Myelin Uptake, and Interaction With Proliferating T Cells , 2006, Journal of neuropathology and experimental neurology.
[3] Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. , 2012, The New England journal of medicine.
[4] S. Zamvil,et al. Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate , 2015, Neurology: Neuroimmunology & Neuroinflammation.
[5] Z. Amirghofran,et al. The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis , 2015, International journal of dermatology.
[6] Y. Osugi,et al. Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. , 2002, Blood.
[7] U. Mrowietz,et al. Dimethylfumarate inhibits nuclear binding of nuclear factor κB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein β in activated human T cells , 2007, The British journal of dermatology.
[8] C. Gasperini,et al. Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing–remitting multiple sclerosis , 2014, Therapeutics and clinical risk management.
[9] D. Arnold,et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. , 2012, The New England journal of medicine.
[10] Felix Treumer,et al. Dimethylfumarate is a potent inducer of apoptosis in human T cells. , 2003, The Journal of investigative dermatology.
[11] N. McGovern,et al. IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses , 2013, Immunity.
[12] R Bonecchi,et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. , 1998, Journal of immunology.
[13] R. Ravid,et al. Expression of CCR7 in multiple sclerosis: Implications for CNS immunity , 2004, Annals of neurology.
[14] Michael J. Ramsbottom,et al. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients , 2016, Multiple sclerosis.
[15] H. Weiner,et al. Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation , 2015, Journal of Neuroinflammation.
[16] Myeloid , 2020, Definitions.
[17] J. Arthur,et al. Mitogen-activated protein kinases in innate immunity , 2013, Nature Reviews Immunology.
[18] E. Tolosa,et al. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. , 2009, Brain : a journal of neurology.
[19] V. Kuchroo,et al. Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes1 , 2009, The Journal of Immunology.
[20] G. Freeman,et al. Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response1 , 2006, The Journal of Immunology.
[21] W. Brück,et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. , 2011, Brain : a journal of neurology.
[22] K. Rhodes,et al. Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway , 2012, Journal of Pharmacology and Experimental Therapeutics.
[23] Christoph Schaniel,et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation , 1998, European journal of immunology.
[24] H. Weiner,et al. IL-23 Is Increased in Dendritic Cells in Multiple Sclerosis and Down-Regulation of IL-23 by Antisense Oligos Increases Dendritic Cell IL-10 Production , 2006, The Journal of Immunology.
[25] J. Schmid,et al. The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.
[26] L. Andersson,et al. Myeloid blood dendritic cells and monocyte-derived dendritic cells differ in their endocytosing capability. , 2012, Human immunology.
[27] Laura Conti,et al. T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β , 2009, Annals of neurology.
[28] H. Wiendl,et al. Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis , 2015, Neurology: Neuroimmunology & Neuroinflammation.
[29] P. Nibbering,et al. Pharmacokinetics of oral fumarates in healthy subjects. , 2004, British journal of clinical pharmacology.
[30] G. Belz,et al. Terminal differentiation of dendritic cells. , 2013, Advances in immunology.
[31] T. Lawrence,et al. Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming , 2014, The EMBO journal.
[32] Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients , 2013, Journal of Neuroimmune Pharmacology.
[33] Yuhong Yang,et al. Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling* , 2012, The Journal of Biological Chemistry.
[34] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[35] P. Nibbering,et al. Effects of monomethylfumarate on dendritic cell differentiation , 2006, The British journal of dermatology.
[36] Martin Röcken,et al. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells , 2012 .